About Us

Halifax's MOC Biotechnologies leads in 4D bioprinting, reaching Canadian Entrepreneurship World Cup finals in 2022. Founded in 2019, they've won national and global awards for their innovation. Their Magical Organ Cloner (MOC) system prints diverse materials, enabling advanced drug discovery, notably in cancer research. Compared to traditional methods, 4D bioprinting offers superior results with natural cell interactions and dynamic tissue structures.